Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
HSBC in advanced talks to sell German fund administration unit to BlackFin
HSBC in advanced talks to sell German fund administration unit to BlackFin HSBC Holdings Plc is close to finalising a deal to sell its German fund administration business, Inka, to BlackFin Capital Partners. The private equity firm is negotiating the acquisition of...
Update: UK Takeover Panel extends deadline for KKR-Stonepeak’s Assura bid to 11 April
Update: UK Takeover Panel extends deadline for KKR-Stonepeak’s Assura bid to 11 April Cinven agreed to sell its majority The UK Takeover Panel has granted KKR and Stonepeak Partners an extension until 11 April to finalise a firm offer for Assura, the healthcare real...
Update: Cinven seals €3.5bn exit from Viridium in landmark Allianz-led deal
Update: Cinven seals €3.5bn exit from Viridium in landmark Allianz-led deal Cinven agreed to sell its majority stake in German life insurance group Viridium to a consortium led by Allianz, BlackRock, and Japan’s T&D Holdings in a €3.5bn transaction. The deal...